Drug Database
Back to search

Canada· CA-DIN-00609900

RINCE BOUCHE ANTISEPTIQUE

A cetylpyridinium product containing cetylpyridinium chloride, registered in Canada by LABORATOIRE ATLAS INC. The same ATC class is registered in 4 of our 19 countries.

ATC R02AA06

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedRINCE BOUCHE ANTISEPTIQUEATCR02AA06REGISTER NO.CA-DIN-00609900PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cetylpyridinium chlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cetylpyridinium is registered in 4 of 19 countries.

Countries holding a registration under ATC R02AA06 (cetylpyridinium), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 3 of them publish a price we can compare per daily dose
Search cetylpyridinium products by name

Cetylpyridinium · ATC R02AA06

4 / 19 countries

  • Canada
  • Czechiaprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
CETYLPYRIDINIUM CHLORIDE
Manufacturer
LABORATOIRE ATLAS INC
Country
Canada (CA)
ATC code
R02AA06
ATC class
Cetylpyridinium
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for cetylpyridinium.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cetylpyridinium against other medicinesHow interaction checks work

Cetylpyridinium · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • Hyaluronic acidM09AX01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cetylpyridinium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cetylpyridinium products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Halset
  • Czechia · Halset, Neoseptolete Třešeň
  • Germany · Anginetten, Halstabletten - Akute Hals- Und Rachenhilfe Zur Anwendung Bei Erwachsenen Und Kindern Ab 3 Jahren
  • France · Sedacollyre
  • United Kingdom (Northern Ireland) · Antiseptic, First Aid Antiseptic
  • Italy · Cetilsan, Cetilsan Senza Zucchero
  • Malta · Cetilsan Sugar Free
  • Norway · Pyrisept
  • Poland · Halset, Septolete Junior
  • Slovenia · Neoseptolete Z Okusom Divje Češnje, Neoseptolete Z Okusom Limone

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0824aa3-79b9-4fa6-9309-a9da2ef78094
GET /v1/drugs/e0824aa3-79b9-4fa6-9309-a9da2ef78094?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "00609900",
  "form": "MOUTHWASH",
  "class": "Human",
  "routes": [
    "BUCCAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "R02AA06",
  "schedule": [
    "OTC"
  ],
  "drug_code": "5812",
  "strengths": [
    "0.05 %"
  ],
  "ahfs_class": null,
  "substances": [
    "CETYLPYRIDINIUM CHLORIDE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about cetylpyridinium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console